Breakthroughs in research may bring hope to 1.5 million Americans suffering from peanut allergy


Please join us for a news conference by phone bringing together the leading peanut allergy experts to discuss the new research in the field and its impact on the 1.5 million Americans suffering from severe peanut allergy. Major breakthroughs in the diagnosis and understanding of peanut allergy are reported on in seven studies in the July 2003 Journal of Allergy and Clinical Immunology (JACI). The JACI is the peer-reviewed journal of the American Academy of Allergy, Asthma and Immunology (AAAAI).

July 10, 2003 at 11 a.m. EST

To register for the press conference, contact John Gardner, 414/272-6071, jgardner@aaaai.org.

Donald Y. M. Leung, MD, PhD, FAAAAI, National Jewish Medical and Research Center, Denver; Editor of the Journal of Allergy and Clinical Immunology
Hugh A. Sampson, MD, FAAAAI, Mt. Sinai School of Medicine
Anne Munoz-Furlong, Founder/CEO, The Food Allergy & Anaphylaxis Network

Peanut allergy is the leading cause of fatal and near-fatal food-induced anaphylaxis in the United States. Each year, thousands of people rush to hospital emergency rooms, and approximately 50 to 100 people die after accidentally eating peanuts. Anaphylactic reactions to peanut can occur at any age and strict avoidance is the only means of preventing an allergic reaction. The latest research presented in the JACI gives new hope to peanut allergy sufferers, while also calming some fears about the dangers of the allergy.

For more information and copies of the studies appearing in the July JACI, contact John Gardner, 414-272-6071 or jgardner@aaaai.org.


Contact: John Gardner
American Academy of Allergy, Asthma & Immunology

Page: 1

Related medicine news :

1. Public morally obliged to take part in scientific research, says leading ethicist
2. U of M researcher says Viagra may cause permanent vision loss in some men
3. Indiana University researchers closer to helping hearing-impaired using stem cells
4. Can you read my mind? W.M. Keck Foundation funds innovative brain research at Carnegie Mellon
5. RIT takes eye-tracking research to next level
6. UW research shows risk factors for relapse among health care professionals who abuse drugs
7. Protein that helps skin cancer spread identified by Stanford researchers
8. US life expectancy about to decline, researchers say
9. Ethical discussion should come before research
10. Philanthropist Paul F. Glenn launches labs for aging research at Harvard Medical School
11. Gene for age-related macular degeneration discovered by Yale researchers

Post Your Comments:

(Date:6/26/2016)... ... 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic ... World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. ... some of the world’s leading providers of cereal and other breakfast foods. Its residents ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the ... AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in ... topics including advance care planning, healthcare costs and patient and family engagement. , ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/24/2016)... ... 24, 2016 , ... Those who have experienced traumatic events may suffer from ... avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid this ... coping following a traumatic event. , Trauma sufferers tend to feel a range of ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... 23, 2016 Bracket , a leading clinical ... generation clinical outcomes platform, Bracket eCOA (SM) 6.0, at ... 26 – 30, 2016 in Philadelphia , ... Outcome Assessment product of its kind to fully integrate with ... Bracket eCOA 6.0 is a flexible platform for electronic clinical ...
Breaking Medicine Technology:
Cached News: